AIM
Aigen Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.44M | Buy |
8,466
+5,807
| +218% | +$3.05M | 0.61% | 20 |
|
2025
Q1 | $1.69M | Sell |
2,659
-3,708
| -58% | -$2.35M | 0.27% | 109 |
|
2024
Q4 | $4.54M | Buy |
6,367
+5,644
| +781% | +$4.02M | 0.8% | 8 |
|
2024
Q3 | $760K | Buy |
+723
| New | +$760K | 0.15% | 205 |
|
2024
Q2 | – | Sell |
-523
| Closed | -$503K | – | 976 |
|
2024
Q1 | $503K | Sell |
523
-134
| -20% | -$129K | 0.11% | 278 |
|
2023
Q4 | $577K | Buy |
+657
| New | +$577K | 0.1% | 288 |
|
2022
Q2 | – | Sell |
-1,206
| Closed | -$842K | – | 694 |
|
2022
Q1 | $842K | Sell |
1,206
-5,977
| -83% | -$4.17M | 0.15% | 192 |
|
2021
Q4 | $4.5M | Buy |
7,183
+335
| +5% | +$210K | 0.28% | 88 |
|
2021
Q3 | $4.14M | Sell |
6,848
-3,771
| -36% | -$2.28M | 0.8% | 28 |
|
2021
Q2 | $5.93M | Buy |
+10,619
| New | +$5.93M | 1.03% | 19 |
|
2021
Q1 | – | Sell |
-1,494
| Closed | -$722K | – | 839 |
|
2020
Q4 | $722K | Buy |
+1,494
| New | +$722K | 0.09% | 287 |
|
2020
Q2 | – | Sell |
-10
| Closed | -$5K | – | 1206 |
|
2020
Q1 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 1168 |
|